MKI67 and neoplasm: This classification follows the unified International Agency for Research on Cancer (IARC)/WHO framework and is based on pathological features such as the Ki-67 labeling index, mitotic rate per 2 mm2, and the presence or absence of necrosis, key indicators of tumor proliferative activity and aggressiveness that guide prognosis and treatment [7].